Available, accessible, aware, appropriate, and acceptable: A strategy to improve participation of teenagers and young adults in cancer trials

The Lancet Oncology

Volumn 15, Issue 8, 2014, Pages

  Fern, Lorna A ^a,b   Lewandowski, Jennifer A ^b   Coxon, Katy M ^b   Whelan, Jeremy ^a,b  

^a UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; AGE DISTRIBUTION; AWARENESS; BRAIN TUMOR; CANCER INCIDENCE; CANCER RESEARCH; CANCER SURVIVAL; CENTRAL NERVOUS SYSTEM TUMOR; CHILDHOOD CANCER; CLINICAL TRIAL (TOPIC); GLIOMA; HEALTH CARE ACCESS; HEALTH SERVICE; HODGKIN DISEASE; HUMAN; OSTEOSARCOMA; PATIENT ADVOCACY; PATIENT PARTICIPATION; PRIORITY JOURNAL; REVIEW; UNITED KINGDOM;

ADOLESCENT; AGE FACTORS; ATTITUDE OF HEALTH PERSONNEL; CLINICAL TRIALS AS TOPIC; GREAT BRITAIN; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH RESOURCES; HEALTH SERVICES ACCESSIBILITY; HUMANS; MODELS, THEORETICAL; NEOPLASMS; PATIENT PARTICIPATION; PATIENT SELECTION; REFERRAL AND CONSULTATION; YOUNG ADULT;

EID: 84903439670     PISSN: 14702045     EISSN: 14745488     Source Type: Journal    
DOI: 10.1016/S1470-2045(14)70113-5     Document Type: Review

References (55)

1. Barr RD Adolescents, young adults, and cancer-the international challenge. Cancer 2011, 117(suppl):2245-2249.
2. Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN (2013). 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11. Lyon: International Agency for Research on Cancer (accessed Feb 13, 2013). http://globocan.iarc.fr.
3. Guidance on cancer services-improving outcomes in children and young people with cancer 2005, NICE, National Institute for Health and Clinical Excellence, London.
4. Bleyer A Older adolescents with cancer in North America deficits in outcome and research. Pediatr Clin North Am 2002, 49:1027-1042.
5. Bleyer A, Montello M, Budd T, Saxman S National survival trends of young adults with sarcoma: lack of progress is associated with lack of clinical trial participation. Cancer 2005, 103:1891-1897.
6. Smith MA, Seibel NL, Altekruse SF, et al. Outcomes for children and adolescents with cancer: challenges for the twenty-first century. J Clin Oncol 2010, 28:2625-2634.
7. Bleyer A, Barr R, Hayes-Lattin B, Thomas D, Ellis C, Anderson B The distinctive biology of cancer in adolescents and young adults. Nat Rev Cancer 2008, 8:288-298. for the Biology and Clinical Trials Subgroups of the US National Cancer Institute Progress Review Group in Adolescent and Young Adult Oncology.
8. Lethaby CD, Picton S, Kinsey SE, Phillips R, van Laar M, Feltbower RG A systematic review of time to diagnosis in children and young adults with cancer. Arch Dis Child 2013, 98:349-355.
9. Bleyer A, Morgan S, Barr R Proceedings of a workshop: bridging the gap in care and addressing participation in clinical trials. Cancer 2006, 107(suppl):1656-1658.
10. Bleyer A, Budd T, Montello M Lack of participation of older adolescents and young adults with cancer in clinical trials: impact in the USA. Cancer and the adolescent 2005, 32-45. Blackwell Science, London. T.O.B. Eden, R.D. Barr, A. Bleyer, M. Whiteson (Eds.).
11. Bleyer A, Montello M, Budd T Young adults with leukemia in the United States: lack of clinical trial participation and mortality reduction during the last decade. J Clin Oncol 2004, 22:6623.
12. Fern L, Davies S, Eden T, et al. Rates of inclusion of teenagers and young adults in England into National Cancer Research Network clinical trials: report from the National Cancer Research Institute (NCRI) Teenage and Young Adult Clinical Studies Development Group. Br J Cancer 2008, 99:1967-1974. for the National Cancer Research Institute (NCRI) Teenage and Young Adult Clinical Studies Development Group.
13. Furlong W, Rae C, Greenberg ML, Barr RD Surveillance and survival among adolescents and young adults with cancer in Ontario, Canada. Int J Cancer 2012, 131:2660-2667.
14. Mitchell AE, Scarcella DL, Rigutto GL, et al. Cancer in adolescents and young adults: treatment and outcome in Victoria. Med J Aust 2004, 180:59-62.
15. Ferrari A, Dama E, Pession A, et al. Adolescents with cancer in Italy: entry into the national cooperative paediatric oncology group AIEOP trials. Eur J Cancer 2009, 45:328-334.
16. Psychosocial management of AYA diagnosed with cancer: guidance of health professionals guidelines and guidance developed by Clinical Oncology Society of Australia, 2013 Australian Cancer Council, (accessed Feb 13, 2014). http://wiki.cancer.org.au/australia/COSA:Psychosocial_management_of_AYA_cancer_patients.
17. O Brien TSA, Thomas D, Treadgold C, Young A The need for change, why we need a new model of care for adolescents and young adults with cancer. A document for discussion. Improving the management of cancer services conference. Melbourne 2006 (accessed Feb 13, 2014). http://canteenlive.netx.com.au/documents/AYA-The_Need_for_Change_C7738.ppt.
18. Rogers PC, De Pauw S, Schacter B, Barr RD A process for change in the care of adolescents and young adults with cancer in Canada. "Moving to Action": the Second Canadian International Workshop. International Perspectives on AYAO, Part 1. J Adolesc Young Adult Oncol 2013, 2:72-76.
19. Closing the gap: research and care imperatives for adolescents and young adults with cancer (NIH publication no. 06-6067). Bethesda: Department of Health and Human Services, National Institutes of Health, National Cancer Institute, and the LIVESTRONG Young Adult Alliance, 2006 US Department of Health, (accessed Feb 13, 2014). http://planning.cancer.gov/library/AYAO_PRG_Report_2006_FINAL.pdf.
20. Teenage and Young Adult Clinical Studies Group Annual Report. London: National Cancer Research Institute, 2013 National Cancer Research Institute, (accessed Feb 13, 2014). http://csg.ncri.org.uk/wp-content/uploads/2013/10/NCRI-CSG_TYA_Annual-Report_2012-2013.pdf.
21. Sinha G United Kingdom becomes the cancer clinical trials recruitment capital of the world. J Natl Cancer Inst 2007, 99:420-422.
22. Pritchard-Jones K, Dixon-Woods M, Naafs-Wilstra M, Valsecchi MG Improving recruitment to clinical trials for cancer in childhood. Lancet Oncol 2008, 9:392-399.
23. Bleyer A, Budd T, Montello M Adolescents and young adults with cancer: the scope of the problem and criticality of clinical trials. Cancer 2006, 107(suppl):1645-1655.
24. Bleyer A, Hag-Alshiekh M, Montello M, et al. Older adolescents and young adults with brain tumors in the United States: lack of clinical trial participation and of survival prolongation and mortality reduction. Neuro Oncol 2004, 6:417.
25. Bleyer WA, Tejeda H, Murphy SB, et al. National cancer clinical trials: children have equal access; adolescents do not. J Adolesc Health 1997, 21:366-373.
26. Ferrari A Adolescents with cancer in Italy: from local projects to a national coordinated program. Tumori 2013, 99:e186-e187.
27. Ford JG, Howerton MW, Lai GY, et al. Barriers to recruiting underrepresented populations to cancer clinical trials: a systematic review. Cancer 2008, 112:228-242.
28. Townsley CA, Selby R, Siu LL Systematic review of barriers to the recruitment of older patients with cancer onto clinical trials. J Clin Oncol 2005, 23:3112-3124.
29. Birch JM, Alston RD, Kelsey AM, Quinn MJ, Babb P, McNally RJ Classification and incidence of cancers in adolescents and young adults in England 1979-1997. Br J Cancer 2002, 87:1267-1274.
30. Ferrari A, Montello M, Budd T, Bleyer A The challenges of clinical trials for adolescents and young adults with cancer. Pediatr Blood Cancer 2008, 50(suppl):1101-1104.
31. Zulman DM, Sussman JB, Chen X, Cigolle CT, Blaum CS, Hayward RA Examining the evidence: a systematic review of the inclusion and analysis of older adults in randomized controlled trials. J Gen Intern Med 2011, 26:783-790.
32. Monfardini S, Sorio R, Boes GH, Kaye S, Serraino D Entry and evaluation of elderly patients in European Organization for Research and Treatment of Cancer (EORTC) new-drug-development studies. Cancer 1995, 76:333-338.
33. Hotta K, Ueoka H, Kiura K, Tabata M, Tanimoto M An overview of 48 elderly-specific clinical trials of systemic chemotherapy for advanced non-small cell lung cancer. Lung Cancer 2004, 46:61-76.
34. Aapro MS, Köhne CH, Cohen HJ, Extermann M Never too old? Age should not be a barrier to enrollment in cancer clinical trials. Oncologist 2005, 10:198-204.
35. Stewart JH, Bertoni AG, Staten JL, Levine EA, Gross CP Participation in surgical oncology clinical trials: gender-, race/ethnicity-, and age-based disparities. Ann Surg Oncol 2007, 14:3328-3334.
36. Cancer Reform Strategy 2007. Chapter 6 Reducing cancer inequalities Department of Health, (accessed Feb 13, 2014). http://www.nhs.uk/NHSEngland/NSF/Documents/Cancer%20Reform%20Strategy.pdf.
37. Studies in support of special populations: geriatrics, 1993. PAB dated Dec 2 (ICH-E7 guideline): notification number 104 of the new drugs division Pharmaceutical and Medical Devices Agency, (accessed Feb 13, 2014). http://www.pmda.go.jp/ich/e/e7_93_12_2e.pdf.
38. Guidelines for industry, studies in support of special populations: geriatrics e7. 1994 FDA, (accessed Feb 13, 2014). http://www.fda.gov/downloads/RegulatoryInformation/Guidances/UCM129519.pdf.
39. ICH harmonised tripartite guideline: studies in support of special populations: geriatrics e7. 1993 International Conference on Harmonisation Expert Working Group, (accessed Feb 13, 2014). http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E7/Step4/E7_Guideline.pdf.
40. Guidelines for industry, studies in support of special populations, E11. Clinical Investigation of medicinal products in the paediatric population 2000 FDA, (accessed Feb 13, 2014). http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM073143.pdf.
41. De Bont JM, Van der Holt B, Dekker AW, Van der Does-Van Den Berg A, Sonneveld P, Pieters R Significant differences in outcome for adolescents with ALL treated on paediatric vs adult ALL protocols in the Netherlands. Leukemia 2004, 18:2032-2053.
42. Stock W, Sather H, Dodge RK, Bloomfield CD, Larson A, Nachman J What determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative group protocols? A comparison of Children's Cancer Group and Cancer and Leukemia Group B studies. Blood 2008, 112:1646-1654.
43. Bleyer A Adolescent and young adult (AYA) oncology: the first A. Pediatr Hematol Oncol 2007, 24:325-336.
44. Howell DL, Ward KC, Austin HD, Young JL, Woods WG Access to pediatric cancer care by age, race, and diagnosis, and outcomes of cancer treatment in pediatric and adolescent patients in the state of Georgia. J Clin Oncol 2007, 25:4610-4615.
45. O'Hara C, Khan MCM, Francis L, Moran T Notifications of teenagers and young adults with cancer to a principle treatment centre, 2009-2010; report from national cancer intelligence network, Manchester, 2013 (accessed Feb 13, 2014). http://www.ncin.org.uk/view?rid=2124.
46. Pearce SBA, Lavender V, Gibson F, Fern L, Whelan J Participation in clinical trials: perceptions of young people with sarcoma and the professionals who look after them. National Cancer Research Institute International Conference; Liverpool, UK; Nov 4-7, 2012. Poster LB103 (accessed Feb 13, 2014). http://conference.ncri.org.uk/abstracts/2012/abstracts/LB103.html.
47. Fern LA, Taylor RM, Whelan J, et al. The art of age-appropriate care: reflecting on a conceptual model of the cancer experience for teenagers and young adults. Cancer Nurs 2013, 36:E27-E38.
48. Murray MJ, Fern LA, Stark DP, Eden TO, Nicholson JC Breaking down barriers: improving outcomes for teenagers and young adults with germ cell tumours. Oncology Reviews 2011, 3:201-206.
49. Taylor RE, Pizer BL, Short S Promoting collaboration between adult and paediatric clinical trial groups. Clin Oncol (R Coll Radiol) 2008, 20:714-716.
50. Ferrari A, Aricò M, Dini G, Rondelli R, Porta F Upper age limits for accessing pediatric oncology centers in Italy: a barrier preventing adolescents with cancer from entering national cooperative AIEOP trials. Pediatr Hematol Oncol 2012, 29:55-61.
51. Ferrari A, Bleyer A Participation of adolescents with cancer in clinical trials. Cancer Treat Rev 2007, 33:603-608.
52. Bleyer A The adolescent and young adult gap in cancer care and outcome. Curr Probl Pediatr Adolesc Health Care 2005, 35:182-217.
53. Brain clinical studies group annual report, 2013 National Cancer Research Institute, (accessed Feb 13, 2013). http://csg.ncri.org.uk/wp-content/uploads/2013/10/NCRI-CSG_Brain_Annual-Report_2012-2013.pdf.
54. Sky News, 2012 (accessed June 12, 2013). http://news.sky.com/story/1083643/mums-plea-after-teen-was-denied-cancer-drugs.
55. Rogers L My girl was judged too young to live. The Sunday Times (London); April 21, 2013; sect 17 (accessed Feb 13, 2014). http://www.thesundaytimes.co.uk/sto/news/uk_news/Health/article1248620.ece.